Clinical Trials Logo

Filter by:
NCT ID: NCT03421171 Recruiting - Anaesthesiology Clinical Trials

Ethical Dilemmas in Anaesthesiology in the Netherlands; a Qualitative Interview Study.

AnaesthEthics
Start date: January 20, 2018
Phase: N/A
Study type: Observational [Patient Registry]

This study will describe which ethical dilemmas are experienced by anesthesiologist in the Dutch Healthcare system and what the current solving strategies are for these issues. Semi- structured interviews will be conducted with anaesthesiologists employed in different hospitals in the Netherlands..

NCT ID: NCT03420742 Completed - Clinical trials for Carcinoma, Advanced ALK+ or ROS1+Non-Small-Cell Lung, Neoplasm, Advanced ALK+ or ROS1+Solid Tumors

A Phase 1 Drug-Drug Interaction Study Between Brigatinib and the CYP3A Substrate, Midazolam, in Participants With ALK-Positive or ROS1-Positive Solid Tumors

Start date: June 26, 2019
Phase: Phase 1
Study type: Interventional

The purpose of this study is to characterize the effect of repeat-dose administration of brigatinib 180 milligram (mg) once daily (QD) on the single-dose pharmacokinetics (PK) of midazolam.

NCT ID: NCT03420235 Completed - Clinical trials for Idiopathic Pulmonary Fibrosis

Home Monitoring in Idiopathic Pulmonary Fibrosis; Improving Use of Anti-fibrotic Medication and Quality of Life

Start date: January 9, 2018
Phase: N/A
Study type: Interventional

In this study it will be investigate whether a home monitoring program improves disease-specific health-related quality of life (HRQOL) for patients with idiopathic pulmonary fibrosis (IPF) through appropriate medication use and subsequently results in better objective and subjective outcomes.

NCT ID: NCT03419702 Completed - Clinical trials for Overweight and Obesity

Almonds and Health Effects on Metabolism, Vascular Function and Cognition

Start date: January 10, 2018
Phase: N/A
Study type: Interventional

The primary objective of the proposed study is to examine and understand the impact of long-term almond consumption on chronic glucose metabolism in subjects with impaired glucose tolerance and/or impaired fasting glucose.

NCT ID: NCT03419572 Completed - Clinical trials for Renal Cell Carcinoma

Non-interventional Study of Cabozantinib in Adults With Advanced Renal Cell Carcinoma

CASSIOPE
Start date: April 24, 2018
Phase:
Study type: Observational

The objective of this study is to understand the utilization of cabozantinib in subjects with advanced renal cell carcinoma (RCC) following prior VEGF-targeted therapy in real life settings in terms of dose modifications due to adverse events (AEs) when used as a second line therapy or third and later line therapy. Other patterns of use of cabozantinib will also be described.

NCT ID: NCT03419403 Terminated - Clinical trials for Glioblastoma Multiforme

UNITE Study: Understanding New Interventions With GBM ThErapy

Start date: July 30, 2018
Phase: Phase 3
Study type: Interventional

The objective of this study was to evaluate the effect of several ophthalmologic prophylactic treatment strategies for the management of ocular side effects (OSEs) in participants with epidermal growth factor receptor (EGFR)-amplified glioblastoma (GBM) who were being treated with depatuxizumab mafodotin (ABT-414).

NCT ID: NCT03418948 Recruiting - Clinical trials for Colorectal Neoplasms

Comparison of AMR and ADR Between Endocuff Vision-assisted and Conventional Colonoscopy: a Multicenter Randomized Trial

EXCEED
Start date: December 8, 2017
Phase: N/A
Study type: Interventional

The aim of this international multicenter study is to compare the adenoma detection rate and adenoma miss rate of conventional and Endocuff Vision-assisted colonoscopy.

NCT ID: NCT03417349 Completed - Stroke, Acute Clinical Trials

Safety and Effectiveness of SOFIA™/SOFIA™ PLUS for Direct Aspiration in Acute Ischemic Stroke

SESAME
Start date: October 1, 2017
Phase:
Study type: Observational

Sesame is a European, multi-center, single arm, prospective, observational registry. Sesame aims to demonstrate that use of SOFIA™/SOFIA™ PLUS catheter for direct aspiration as a first line treatment technique is fast, safe and effective in patients suffering an Acute Ischemic Stroke when assessed at 24 hours, discharge and 90 days after treatment. 250 patients will be enrolled. All patients will be followed for 90 days or until death.

NCT ID: NCT03417011 Completed - Clinical trials for Aortic Valve Stenosis

FORWARD PRO Study Interventional Post-market Study With the Evolut™ PRO System

Start date: February 26, 2018
Phase:
Study type: Observational

Prospective, single-arm, multi-center, interventional post-market study. After signing informed consent, eligible subjects will be implanted with the CE marked Evolut™ PRO system. The investigation purpose is to evaluate the acute and long term clinical performance and safety of Evolut™ PRO in a routine hospital setting in patients with symptomatic native aortic valve stenosis or a stenosed, insufficient, or combined surgical bioprosthetic valve failure necessitating valve replacement within the approved intended use in local geography.

NCT ID: NCT03416270 Completed - Heart Failure Clinical Trials

ERtugliflozin triAl in DIabetes With Preserved or Reduced ejeCtion FrAcTion mEchanistic Evaluation in Heart Failure

ERADICATE-HF
Start date: June 28, 2018
Phase: Phase 2
Study type: Interventional

This study aims to elucidate the mechanisms whereby the SGLT2i "ertugliflozin" modifies cardiorenal interactions that regulate fluid volume and neurohormonal activation in patients with type 2 diabetes and heart failure (T2D-HF).